Oral Answers to Questions Debate
Full Debate: Read Full DebateGareth Thomas
Main Page: Gareth Thomas (Labour (Co-op) - Harrow West)Department Debates - View all Gareth Thomas's debates with the Department for International Trade
(2 years, 2 months ago)
Commons ChamberThe right hon. Lady’s question is very timely. The negotiations are going on as we speak, so I do not want to comment on those live negotiations. She will know that we firmly believe that having strong intellectual property rights is key to ensuring that investment is going into the science base and that these products and vaccines will continue to be developed. We need that to happen, as well as to ensure that there is equity and that the world can make use of these amazing products.
Perhaps the reason that the Minister of State does not want to give any more detail is that in Geneva this week the Secretary of State has actually been leading efforts to water down or block any deal on access to covid medicines. I gently ask the Minister of State this: with so few people in developing countries having had their first covid vaccine, why are Ministers so determined to prevent some of the richest companies across the globe from giving the poorest people in the world the tools they need to stop transmission and save lives?
That is a ridiculous mischaracterisation of this country’s stance. We are one of the largest donors to the covid advance market commitment, which is ensuring that the vaccine is being rolled out in 92 developing countries. We are at the forefront of that effort. What the Secretary of State is trying to do is ensure that investment in the science base that created these vaccines remains strong. We need to do both of those things if we are going to vaccinate the world.
Given that the Prime Minister’s poor trade deal with the EU has already damaged exports and cost jobs, as my hon. Friend the Member for Ogmore (Chris Elmore) says, the warnings from business groups this week that the Northern Ireland Protocol Bill risks further damage to trade and investment ought to have rung very loud alarm bells across Whitehall. Will Ministers commit to publishing, before the Bill’s Second Reading, an analysis of its implications for British exporters and all those whose jobs depend on exports to European markets?
I will take away the hon. Gentleman’s request and discuss it with colleagues.